Publications

Department of Medicine faculty members published more than 3,600 peer-reviewed articles in 2024.

Filter by

Circulation. Cardiovascular genetics

General Cardiovascular Risk Profile identifies advanced coronary artery calcium and is improved by family history: the multiethnic study of atherosclerosis.

2009

Authors: Scheuner MT, Setodji CM, Pankow JS, Blumenthal RS, Keeler E

PloS one

Activin signaling in microsatellite stable colon cancers is disrupted by a combination of genetic and epigenetic mechanisms.

2009

Authors: Jung B, Gomez J, Chau E, Cabral J, Lee JK, Anselm A, Slowik P, Ream-Robinson D, Messer K, Sporn J, Shin SK, Boland CR, Goel A, Carethers JM

Archives of internal medicine

Spouse-rated vs self-rated health as predictors of mortality.

2009

Authors: Ayalon L, Covinsky KE

Infection and immunity

Pseudomonas aeruginosa-mediated damage requires distinct receptors at the apical and basolateral surfaces of the polarized epithelium.

2009

Authors: Bucior I, Mostov K, Engel JN

Archives of internal medicine

A comparison of prediction models for fractures in older women: is more better?

2009

Authors: Ensrud KE, Lui LY, Taylor BC, Schousboe JT, Donaldson MG, Fink HA, Cauley JA, Hillier TA, Browner WS, Cummings SR

Volume 169 of Issue 22 | Archives of internal medicine

Cancer risks and radiation exposure from computed tomographic scans: how can we be sure that the benefits outweigh the risks?

2009

Authors: Redberg RF

Nature cell biology

A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response.

2009

Authors: Ashida H, Kim M, Schmidt-Supprian M, Ma A, Ogawa M, Sasakawa C

Journal of urban health : bulletin of the New York Academy of Medicine

Emergency contraception for newly arrested women: evidence for an unrecognized public health opportunity.

2009

Authors: Sufrin CB, Tulsky JP, Goldenson J, Winter KS, Cohan DL

Volume 115 of Issue 2 | Cardiology

Doxorubicin cardiomyopathy.

2009

Authors: Chatterjee K, Zhang J, Honbo N, Karliner JS

View Abstract

Established doxorubicin cardiomyopathy is a lethal disease. When congestive heart failure develops, mortality is approximately 50%. Extensive research has been done to understand the mechanism and pathophysiology of doxorubicin cardiomyopathy, and considerable knowledge and experience has been gained. Unfortunately, no effective treatment for established doxorubicin cardiomyopathy is presently available. Extensive research has been done and is being done to discover preventive treatments. However an effective and clinically applicable preventive treatment is yet to be discovered.

View on PubMed

Journal of bacteriology

Genetic analysis of the regulation of type IV pilus function by the Chp chemosensory system of Pseudomonas aeruginosa.

2009

Authors: Bertrand JJ, West JT, Engel JN